Clicky

Fusion Antibodies PLC(FAB)

Description: Fusion Antibodies PLC, formerly Fusion Antibodies, Ltd., is a United Kingdom-based cancer therapeutics developer. The Company develops and commercializes antibody-based therapeutics for cancer. The Company develops a range of antibody engineering services based around monoclonal antibodies. It focuses in the expression and purification of recombinant proteins and chimeric antibodies for the research, diagnostic and therapeutic markets. Its technology generates target specific antibodies from protein antigens. The Company's therapeutic and diagnostic research and development are offered as a service to pharmaceutical, biopharmaceutical and academic researchers.


Keywords: Biotechnology Pharmaceutical Cancer Engineering Biopharmaceutical Life Sciences Immunology Immune System Antibodies Monoclonal Antibodies Antibody Glycoproteins Cancer Therapeutics Recombinant Proteins Fusion Protein Therapeutics For Cancer Monoclonal H. Michael Shepard

Home Page: www.fusionantibodies.com

FAB Technical Analysis

1 Springbank Road
Belfast, BT17 0QL
United Kingdom
Phone: 44 28 9043 2800


Officers

Name Title
Mr. James Fair CFO, Company Sec. & Director
Dr. Richard John Buick Ph.D. Chief Scientific Officer & Director
Dr. Adrian Kinkaid Ph.D. CEO & Director
Prof. Jim Johnston Founder
Mr. Hugh Morgan Ph.D. Director of Operations
Dr. Paul Gerard Kerr Consultant

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 4.1976
Price-to-Sales TTM: 2.5577
IPO Date:
Fiscal Year End: March
Full Time Employees: 55
Back to stocks